Erratum to “The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization. Cardiovasc Revasc Med 2012;13:11-9”




In the following manuscript, Cardiovasc Revasc Med 2012;13:11-9 by Fefer P, et al. “The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization,” ( ) the name of the 5th author should read: Fumiyuki Otsuka (not Otsuma).


Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: Single center experience
  2. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: Results from the ISAR-DESIRE 2 trial
  3. Guide-catheter extension system facilitated multiple bioresorbable vascular scaffolds (ABSORB®) delivery in a very long and resistant coronary artery lesion
  4. A giant right coronary artery related to a small fistula to the coronary sinus

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 14, 2017 | Posted by in CARDIOLOGY | Comments Off on Erratum to “The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization. Cardiovasc Revasc Med 2012;13:11-9”

Full access? Get Clinical Tree
Get Clinical Tree app for offline access